Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Aluzine

    Client Email Product

    Aluzine

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    38
    US DMFs Filed

    US DMFs Filed

    20
    CEP/COS Certifications

    CEP/COS Certifications

    9
    JDMFs Filed

    JDMFs Filed

    5
    Other Certificates

    Other Certificates

    4
    Other Suppliers

    Other Suppliers

    22
    API REF. PRICE (USD / KG)
    48

    API Market Place

    37
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    93
    Europe

    Europe

    103
    Canada

    Canada

    26
    Australia

    Australia

    27
    South Africa

    South Africa

    37
    Uploaded Dossiers

    Uploaded Dossiers

    41
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    912.00

    Annual Reports

    0

    FDF Market Place

    40
    EXCIPIENTS
    166
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    3

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    4

    News

    29
    REF STANDARD

    EDQM

    3

    USP

    2

    JP

    4

    Other Listed Suppliers

    10
    SERVICES
    1
    left grey arrow
    right gray arrow
    • TABLET;ORAL - 20MG
    • TABLET;ORAL - 40MG
    • TABLET;ORAL - 80MG
    • INJECTABLE;INJECTION - 10MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    Full View ScreenFull Screen View
    scPharmaceuticals Enrolls First FUROSCIX Auto-Injector Study Patient
    scPharmaceuticals Enrolls First FUROSCIX Auto-Injector Study Patient

    https://www.globenewswire.com/news-release/2024/04/24/2868561/0/en/scPharmaceuticals-Announces-First-Participant-Enrolled-in-Pivotal-Pharmacokinetic-Study-of-FUROSCIX-Auto-Injector-furosemide-80mg-mL-Injection.html

    GLOBENEWSWIRE
    24 Apr 2024
    Share Share
    Saba İlaç's Generic Furosemide Receives Approvals in the U.S
    Saba İlaç's Generic Furosemide Receives Approvals in the U.S

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215856

    FDA
    02 Apr 2024
    Share Share
    Avenacy Announces Launch of Furosemide for Injection in the U.S. Market
    Avenacy Announces Launch of Furosemide for Injection in the U.S. Market

    https://www.businesswire.com/news/home/20240320953949/en

    BUSINESSWIRE
    20 Mar 2024
    Share Share
    Intas Pharmaceuticals Limited on FDA Import Alert List
    Intas Pharmaceuticals Limited on FDA Import Alert List

    https://www.accessdata.fda.gov/cms_ia/importalert_189.html

    FDA
    06 Jun 2023
    Share Share
    Enforcement Report - Week of January 18, 2023
    Enforcement Report - Week of January 18, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-18-2023-33998.pdf

    FDA
    18 Jan 2023
    Share Share
    Mankind's Generic Furosemide Receives Approval in the U.S.
    Mankind's Generic Furosemide Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216860

    FDA
    16 Dec 2022
    Share Share
    Salix Will Present Rifaximin Data at AASLD's The Liver Meeting(R) 2022
    Salix Will Present Rifaximin Data at AASLD's The Liver Meeting(R) 2022

    https://www.accesswire.com/723896/Salix-Will-Present-Rifaximin-Data-at-AASLDs-The-Liver-MeetingR-2022

    ACCESSWIRE
    04 Nov 2022
    Share Share
    Graviti's Generic Furosemide Receives Approval in the U.S.
    Graviti's Generic Furosemide Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216629

    FDA
    17 Oct 2022
    Share Share
    FDA signs off on scPharmaceutical’s on-body infusor for HF
    FDA signs off on scPharmaceutical’s on-body infusor for HF

    https://www.fiercepharma.com/drug-delivery/scpharmaceuticals-finally-wins-fda-nod-its-body-infusor-congestive-heart-failure

    Kevin Dunleavy FIERCEPHARMA
    11 Oct 2022
    Share Share
    scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide)
    scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide)

    https://www.globenewswire.com/news-release/2022/10/10/2530966/0/en/scPharmaceuticals-Announces-FDA-Approval-of-FUROSCIX-furosemide-injection-the-First-and-Only-Self-administered-Subcutaneous-Loop-Diuretic-for-the-At-home-Treatment-of-Congestion-in.html

    GLOBENEWSWIRE
    10 Oct 2022
    Share Share
    scPharmaceuticals to Host FUROSCIX 80mg/10mL for Subcutaneous Administration
    scPharmaceuticals to Host FUROSCIX 80mg/10mL for Subcutaneous Administration

    https://www.globenewswire.com/news-release/2022/06/30/2472067/0/en/scPharmaceuticals-Inc-to-Host-FUROSCIX-furosemide-80mg-10mL-for-Subcutaneous-Administration-Commercial-Day-An-Investigational-Treatment-for-Heart-Failure-Patients.html

    GLOBENEWSWIRE
    30 Jun 2022
    Share Share
    Hong Kong's Generic Furosemide Receives Approval in the U.S.
    Hong Kong's Generic Furosemide Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212803

    FDA
    27 Jan 2022
    Share Share
    scPharmaceuticals Hosting Key Opinion Leader Call on FUROSCIX
    scPharmaceuticals Hosting Key Opinion Leader Call on FUROSCIX

    https://www.businesswire.com/news/home/20200917005270/en

    BUSINESSWIRE
    16 Sep 2020
    Share Share
    Gland Pharma`s Generic Furosemide Receives Approval in US
    Gland Pharma`s Generic Furosemide Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213902

    FDA
    03 Jul 2020
    Share Share
    Aurobindo Pharma`s Generic Furosemide Receives Approval in US
    Aurobindo Pharma`s Generic Furosemide Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212174

    FDA
    07 May 2019
    Share Share
    Enforcement Report - Week of September 19, 2018
    Enforcement Report - Week of September 19, 2018

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-19-2018-1537361296.pdf

    FDA
    19 Sep 2018
    Share Share
    SCA Pharmaceuticals Voluntarily Recalls Furosemide in 0.9% Sodium Chloride
    SCA Pharmaceuticals Voluntarily Recalls Furosemide in 0.9% Sodium Chloride

    https://www.fda.gov/Safety/Recalls/ucm619776.htm

    FDA
    08 Sep 2018
    Share Share
    Optimized Furosemide Taste Masked Orally Disintegrating Tablet
    Optimized Furosemide Taste Masked Orally Disintegrating Tablet

    https://www.pharma-excipients.ch/2017/04/20/optimized-furosemide-taste-masked-orally-disintegrating-tablet/

    PHARMA EXCIPENTS
    19 Apr 2017
    Share Share
    Taste acceptance of Captopril and Furosemide Extemporaneous Oral Pediatric
    Taste acceptance of Captopril and Furosemide Extemporaneous Oral Pediatric

    http://www.pharma-excipients.ch/2016/08/11/taste-acceptance-of-captopril-and-furosemide-extemporaneous-oral-pediatric-formulations-among-hospitalized-children/

    PHARMA-EXCIPIENTS
    11 Aug 2016
    Share Share
    Claris Lifesciences UK Recalls Furosemide 20mg/2ml Injection
    Claris Lifesciences UK Recalls Furosemide 20mg/2ml Injection

    https://www.pharmacompass.com/pdf/news/claris-lifesciences-uk-recalls-furosemide-20mg2ml-injection-1471071338.pdf

    MHRA
    11 Aug 2016
    Share Share
    Taste acceptance of Captopril and Furosemide Extemporaneous Oral Formulation
    Taste acceptance of Captopril and Furosemide Extemporaneous Oral Formulation

    http://www.pharma-excipients.ch/2016/08/11/taste-acceptance-of-captopril-and-furosemide-extemporaneous-oral-pediatric-formulations-among-hospitalized-children/

    PHARMA-EXCIPIENTS
    10 Aug 2016
    Share Share
    Amneal Receives FDA Nod For Generic Furosemide
    Amneal Receives FDA Nod For Generic Furosemide

    https://www.pharmacompass.com/pdf/news/amneal-receives-fda-nod-for-generic-furosemide-1469261909.pdf

    FDA
    20 Jul 2016
    Share Share
    Polymeric microcontainers improve oral bioavailability of furosemide
    Polymeric microcontainers improve oral bioavailability of furosemide

    http://www.pharma-excipients.ch/2016/04/03/polymeric-microcontainers-improve-oral-bioavailability-of-furosemide/

    PHARMA-EXCIPIENTS
    04 Apr 2016
    Share Share
    Rusan Pharma Ltd fails EDQM Inspection
    Rusan Pharma Ltd fails EDQM Inspection

    https://www.pharmacompass.com/pdf/news/Rusan-Pharma-Ltd-fails-EDQM-Inspections-1459848264.pdf

    EDQM
    04 Apr 2016
    Share Share
    Essential medicines containing ethanol elevate blood acetaldehyde concentrations
    Essential medicines containing ethanol elevate blood acetaldehyde concentrations

    http://www.pharma-excipients.ch/2016/03/26/essential-medicines-containing-ethanol-elevate-blood-acetaldehyde-concentrations-in-neonates/

    PHARMA-EXCIPIENTS
    27 Mar 2016
    Share Share
    Italy bans 7 APIs from compounding pharmacies after off-label abuse
    Italy bans 7 APIs from compounding pharmacies after off-label abuse

    http://www.in-pharmatechnologist.com/Processing/Italy-bans-7-APIs-from-compounding-pharmacies-after-off-label-abuse

    Fiona Barry IN-PHARMA TECHNOLOGIST
    21 Aug 2015
    Share Share
    Alveda Furosemide Injection USP 10 mg/mL - Recall of One Lot Due to the Same Barcode as Alveda Epinephrine Injection USP 1 mg/mL
    Alveda Furosemide Injection USP 10 mg/mL - Recall of One Lot Due to the Same Barcode as Alveda Epinephrine Injection USP 1 mg/mL

    http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/53515a-eng.php

    HEALTHY CANADIANS
    22 May 2015
    Share Share
    FDA raises alert on chinese drug for joint pain
    FDA raises alert on chinese drug for joint pain

    http://www.biospectrumasia.com/biospectrum/regulatory/221165/fda-raises-alert-chinese-drug-joint-pain

    Biospectrum Bureau BIOSPECTRUM ASIA
    06 May 2015
    Share Share
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30

    Eric Palmer FIERCE PHARMA MFG
    02 May 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    EUROAPI furosemide

    Access Virtual Booth

    Contact Supplier

    View Presentation

    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search